NL153305B
(nl)
*
|
1969-06-05 |
1977-05-16 |
Philips Nv |
Verwarmingsinstallatie, in het bijzonder geschikt voor voertuigen, voorzien van een heetgasmotor.
|
US3717993A
(en)
*
|
1970-11-02 |
1973-02-27 |
Gen Motors Corp |
Preheater assembly for stirling engine
|
NL7205878A
(fr)
*
|
1972-04-29 |
1973-10-31 |
|
|
JPS62116867A
(ja)
*
|
1985-11-16 |
1987-05-28 |
アイシン精機株式会社 |
冷凍装置
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
DK1035834T3
(da)
|
1997-12-05 |
2002-07-08 |
Alza Corp |
Osmotisk doseringsform omfattende en første og anden coating
|
RS50070B
(sr)
|
1997-12-22 |
2009-01-22 |
Euro-Celtique S.A., |
Oralni dozni oblik sa kombinacijom opijatnog agonista i antagonista
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
EP2263658A1
(fr)
|
2000-10-30 |
2010-12-22 |
Euro-Celtique S.A. |
Formulations d'hydrocodone à liberation lente
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
DK2425824T5
(en)
|
2002-04-05 |
2018-02-12 |
Mundipharma As |
Pharmaceutical preparation containing oxycodone and naloxone
|
JP2007524616A
(ja)
*
|
2003-06-20 |
2007-08-30 |
ヴァイラル・ジェノミックス・インコーポレーテッド |
Hivを処置するための組成物および方法
|
EP1663229B1
(fr)
|
2003-09-25 |
2010-04-14 |
Euro-Celtique S.A. |
Combinaisons pharmaceutiques d'hydrocodone et de naltrexone
|
TWI483944B
(zh)
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
EP1604666A1
(fr)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioides pour le traitement de la bronchopneumopathie chronique obstructive
|
EP1604667A1
(fr)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioides pour le traitement des impatiences des membres inférieurs
|
SI1765292T1
(en)
|
2004-06-12 |
2018-04-30 |
Collegium Pharmaceutical, Inc. |
Formulations of medicines to discourage abuse
|
KR20090029856A
(ko)
*
|
2005-01-28 |
2009-03-23 |
유로-셀띠끄 소시에떼 아노님 |
알코올 저항성 제형
|
EP1702558A1
(fr)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Procédé et dispositif pour évaluer la fonction de l'activité intestinale
|
EP1695700A1
(fr)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Forme posologique contenant de l'oxycodone et de la naloxone
|
EP1813276A1
(fr)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Formes de dosage inviolables
|
US20120065221A1
(en)
|
2009-02-26 |
2012-03-15 |
Theraquest Biosciences, Inc. |
Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
|
WO2010103039A1
(fr)
|
2009-03-10 |
2010-09-16 |
Euro-Celtique S.A. |
Compositions pharmaceutiques à libération immédiate comportant de l'oxycodone et du naloxone
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
SG191288A1
(en)
|
2010-12-22 |
2013-07-31 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
JP5638151B2
(ja)
|
2010-12-23 |
2014-12-10 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
不正加工抵抗性の(tamperresistant)固形経口剤形
|
WO2014013311A1
(fr)
|
2012-07-16 |
2014-01-23 |
Rhodes Technologies |
Procédé pour améliorer la synthèse d'opioïdes
|
EP2872516B1
(fr)
|
2012-07-16 |
2017-08-30 |
Rhodes Technologies |
Procédé pour la synthèse améliorée d'opioïdes
|
US9149533B2
(en)
|
2013-02-05 |
2015-10-06 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
AU2014295042B2
(en)
|
2013-07-23 |
2017-03-30 |
Mundipharma Pty Limited |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
CN106029669B
(zh)
|
2014-01-15 |
2018-04-13 |
罗德科技公司 |
改进的羟二氢吗啡酮合成的方法
|
US9932348B2
(en)
|
2014-01-15 |
2018-04-03 |
Rhodes Technologies |
Process for improved oxycodone synthesis
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
CN114174661B
(zh)
*
|
2019-05-21 |
2024-08-30 |
通用电气公司 |
具有底循环系统的闭式循环发动机
|